G protein‐coupled receptor hetero‐dimerization: contribution to pharmacology and function
- 25 August 2009
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 158 (1), 5-14
- https://doi.org/10.1111/j.1476-5381.2009.00169.x
Abstract
The concept that G protein-coupled receptors (GPCRs) can form hetero-dimers or hetero-oligomers continues to gain experimental support. However, with the exception of the GABAB receptor and the sweet and umami taste receptors few reported examples meet all of the criteria suggested in a recent International Union of Basic and Clinical Pharmacology sponsored review (Pin et al., 2007) that should be required to define distinct and physiologically relevant receptor species. Despite this, there are many examples in which pairs of co-expressed GPCRs reciprocally modulate their function, trafficking and/or ligand pharmacology. Such data are at least consistent with physical interactions between the receptor pairs. In recent times, it has been suggested that specific GPCR hetero-dimer or hetero-oligomer pairs may represent key molecular targets of certain clinically effective, small molecule drugs and there is growing interest in efforts to identify ligands that may modulate hetero-dimer function selectively. The current review summarizes key recent developments in these topics. British Journal of Pharmacology (2009) 158, 5-14; doi:10.1111/j.1476-5381.2009.00169.x; published online 20 March 2009Keywords
This publication has 107 references indexed in Scilit:
- Heterodimerization and surface localization of G protein coupled receptorsBiochemical Pharmacology, 2007
- Physical Association between Neuropeptide FF and μ-Opioid Receptors as a Possible Molecular Basis for Anti-opioid ActivityPublished by Elsevier BV ,2007
- International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the Recognition and Nomenclature of G Protein-Coupled Receptor HeteromultimersPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2007
- Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect BehaviorNeuron, 2007
- The α1b-Adrenoceptor Exists as a Higher-Order Oligomer: Effective Oligomerization Is Required for Receptor Maturation, Surface Delivery, and FunctionPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2007
- D1–D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of G q /11 in the striatumProceedings of the National Academy of Sciences, 2007
- BRET analysis of GPCR oligomerization: newer does not mean betterNature Methods, 2007
- Orexin-1 Receptor-Cannabinoid CB1 Receptor Heterodimerization Results in Both Ligand-dependent and -independent Coordinated Alterations of Receptor Localization and FunctionJournal of Biological Chemistry, 2006
- Impact of GPCRs in clinical medicine: Monogenic diseases, genetic variants and drug targetsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- G protein-coupled receptor dimerisation: Molecular basis and relevance to functionBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006